SIMPONI 50 MG SOL INJ CT 1 SER PREENC X 0,5 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1123634050010
  • GGREM 514520070037607
  • Código de barras 7896212424474

O que a fonte publica

Detentor do registro
JANSSEN-CILAG FARMACEUTICA LTDA
Princípios ativos
GOLIMUMABE
Embalagem
50 MG SOL INJ CT 1 SER PREENC X 0,5 ML
Tipo de produto
Biológico
Classe terapêutica
L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:514520070037607
{
  "name": "SIMPONI 50 MG SOL INJ CT 1 SER PREENC X 0,5 ML",
  "holder": "JANSSEN-CILAG FARMACEUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7896212424474"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "514520070037607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "51.780.468/0001-87",
  "priceRegime": "Regulado",
  "productName": "SIMPONI",
  "productType": "Biológico",
  "hospitalOnly": false,
  "presentation": "50 MG SOL INJ CT 1 SER PREENC X 0,5 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "4678.12",
    "icms-12": "5316.05",
    "icms-17": "5636.29",
    "icms-18": "5705.02",
    "icms-19": "5775.46",
    "icms-20": "5847.65",
    "icms-21": "5921.67",
    "icms-22": "5997.59",
    "icms-23": "6075.48",
    "icms-17.5": "5670.45",
    "icms-19.5": "5811.33",
    "icms-20.5": "5884.43",
    "icms-22.5": "6036.29",
    "icms-12-alc": "5252.25",
    "icms-17-alc": "5568.65",
    "icms-18-alc": "5636.56",
    "icms-19-alc": "5706.15",
    "icms-20-alc": "5777.47",
    "icms-21-alc": "5850.61",
    "icms-22-alc": "5925.62",
    "icms-23-alc": "6002.57",
    "withoutTaxes": "4621.98",
    "icms-17.5-alc": "5602.40",
    "icms-19.5-alc": "5741.59",
    "icms-20.5-alc": "5813.81",
    "icms-22.5-alc": "5963.85"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "GOLIMUMABE",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "6448.30",
    "icms-12": "7327.62",
    "icms-17": "7769.04",
    "icms-18": "7863.78",
    "icms-19": "7960.87",
    "icms-20": "8060.38",
    "icms-21": "8162.41",
    "icms-22": "8267.05",
    "icms-23": "8374.42",
    "icms-17.5": "7816.12",
    "icms-19.5": "8010.31",
    "icms-20.5": "8111.07",
    "icms-22.5": "8320.40",
    "icms-12-alc": "7260.93",
    "icms-17-alc": "7698.33",
    "icms-18-alc": "7792.21",
    "icms-19-alc": "7888.42",
    "icms-20-alc": "7987.01",
    "icms-21-alc": "8088.13",
    "icms-22-alc": "8191.82",
    "icms-23-alc": "8298.20",
    "withoutTaxes": "6389.62",
    "icms-17.5-alc": "7744.99",
    "icms-19.5-alc": "7937.41",
    "icms-20.5-alc": "8037.25",
    "icms-22.5-alc": "8244.67"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "GOLIMUMABE"
  ],
  "therapeuticClass": "L4B - PRODUTOS ANTI-TNF( FATOR DE NECROSE TUMORAL)",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1123634050010",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L4B",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:514520070037607"